| Michael Shane Harris, PA-C | |
|
3330 Masonic Dr, Alexandria, LA 71301-3841 | |
| (318) 449-2415 | |
| Not Available |
| Full Name | Michael Shane Harris |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 17 Years |
| Location | 3330 Masonic Dr, Alexandria, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275847394 | NPI | - | NPPES |
| 2353454 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA.200360 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus St Frances Cabrini Hospital | Alexandria, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christus Trinity Clinic | 3072426741 | 1227 |
News Archive
Fissurectomy results in high levels of healing and low rates of anal incontinence, show the results of the largest ever prospective study of the technique.
The March of Dimes and seven former directors of the U.S. Centers for Disease Control and Prevention (CDC) today urged parents not to be frightened of childhood vaccines by the suggestion in an upcoming episode of the ABC-TV drama, "Eli Stone" that the mercury-based preservative thimerosal - which is no longer used in vaccines may lead to autism.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
Researchers have discovered how a hormone in the gut slows the rate at which the stomach empties and thus suppresses hunger and food intake. Results of the animal study will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Shane Harris, PA-C 919 Hidden Rdg, Irving, TX 75038-3813 Ph: (469) 282-2711 | Michael Shane Harris, PA-C 3330 Masonic Dr, Alexandria, LA 71301-3841 Ph: (318) 449-2415 |
News Archive
Fissurectomy results in high levels of healing and low rates of anal incontinence, show the results of the largest ever prospective study of the technique.
The March of Dimes and seven former directors of the U.S. Centers for Disease Control and Prevention (CDC) today urged parents not to be frightened of childhood vaccines by the suggestion in an upcoming episode of the ABC-TV drama, "Eli Stone" that the mercury-based preservative thimerosal - which is no longer used in vaccines may lead to autism.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
CPEX Pharmaceuticals Inc. today announced that its partner, Serenity Pharmaceuticals, has entered into a global agreement with Allergan, Inc. for the development and commercialization of Ser-120, a product candidate currently in Phase III clinical trials for the treatment of nocturia that utilizes CPEX's patented intranasal drug delivery technology.
Researchers have discovered how a hormone in the gut slows the rate at which the stomach empties and thus suppresses hunger and food intake. Results of the animal study will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.
› Verified 6 days ago
Dustin Rand Goudeau, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3351 Masonic Dr, Alexandria, LA 71301 Phone: 318-473-9556 Fax: 318-441-8339 | |
Chrishonda Marie Whitlock, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3330 Masonic Dr, Alexandria, LA 71301 Phone: 318-487-1122 | |
Ms. Kelly G White, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 605b Medical Center Dr, Alexandria, LA 71301 Phone: 318-442-2232 Fax: 318-442-2192 | |
Elizabeth Kathleen Robichaux, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 221 Windermere Blvd, Alexandria, LA 71303 Phone: 318-443-9773 Fax: 318-443-9799 | |
Savanah Booker, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3601 Jackson St, Alexandria, LA 71303 Phone: 318-787-6877 | |
Mr. Charles M Johnson Jr., PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3444 Masonic Drive, Alexandria, LA 71301 Phone: 318-473-9556 Fax: 318-441-8310 | |
Kevin James Murphy, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3704 North Blvd, Suite C, Alexandria, LA 71301 Phone: 318-443-4576 Fax: 318-449-5579 |